THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
STAKEHOLDER FORUM 2015 - SAVE THE DATE
This year's IMI Stakeholder Forum will take place on Monday 15 June in Brussels, Belgium.
Join us to learn about IMI's achievements so far and give input on our future activities and plans!
- 01/04/2015 : RT @patientpowereu: “@jangeissler @eupatients director, believes #patients must be involved in drugs development http://t.co/dHXjuXXXEs #pa…
- 01/04/2015 : Join #diabetes project SUMMIT in Malmö on 22/4 for symposium on diabetes complications http://t.co/i9RTVTsQUG
- 01/04/2015 : Tomorrow is World #Autism Awareness Day – our EU-AIMS project is shedding new light on the underlying causes http://t.co/i9MAJO45tF #WAAD